-
Innovation Ranking
NewInnovation Ranking – LEO Group Co Ltd
Leo Group Co Ltd (Leo Group) is a manufacturing company. It carries out the research and development, manufacturing and sales of pumps, garden machinery, cleaning, and plant protection machinery, among others. The company product portfolio includes domestic pump, commercial pump, hydraulic engineering pump, petrochemical engineering pump, power engineering pump and garden machinery. The company provide sales and service network. Leo Group also offers internet services which includes digital marketing services, digital media agency services, data integration services and precision marketing...
-
Product Insights
NewAtopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Atopic Dermatitis Clinical Trials Market Report Overview In total, there were 2,258 clinical trials conducted on atopic dermatitis (atopic eczema), as of March 2024. The atopic dermatitis clinical trial market research report provides an overview of the Atopic Dermatitis clinical trials scenario. This report provides top-line data relating to the clinical trials on Atopic dermatitis. The report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LEO-152020 in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Atopic Dermatitis (Atopic Eczema) Drug Details: LEO-152020 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LEO-134310 in Plaque Psoriasis (Psoriasis Vulgaris)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LEO-134310 in Plaque Psoriasis (Psoriasis Vulgaris) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LEO-134310 in Plaque Psoriasis (Psoriasis Vulgaris) Drug Details: LEO-134310 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Temtokibart in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Temtokibart in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Temtokibart in Atopic Dermatitis (Atopic Eczema) Drug Details: Temtokibart...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Atopic Dermatitis (Atopic Eczema) Drug Details: Delgocitinib (Corectim)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LEO-152020 in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LEO-152020 in Chronic Urticaria Or Hives report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LEO-152020 in Chronic Urticaria Or Hives Drug Details: LEO-152020 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pacmilimab in Cervical Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pacmilimab in Cervical Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pacmilimab in Cervical Cancer Drug Details: CX-072 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Atezolizumab in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Atezolizumab in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Atezolizumab in Follicular Lymphoma Drug Details: Atezolizumab (Tecentriq) is an antineoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Delgocitinib in Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Delgocitinib in Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Delgocitinib in Alopecia Drug Details: Delgocitinib (Corectim) acts as anti-allergic agent. It is...